Dr. Ryan Evans, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,632 | 106 | 84.7% |
| Education | $270.97 | 4 | 14.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.97 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $751.72 | 64 | $0 (2024) |
| Celgene Corporation | $293.06 | 18 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $282.89 | 7 | $0 (2022) |
| Amgen Inc. | $200.16 | 4 | $0 (2019) |
| Allergan, Inc. | $191.94 | 8 | $0 (2021) |
| Lilly USA, LLC | $43.93 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $27.04 | 1 | $0 (2020) |
| Roche Diagnostics Corporation | $24.00 | 1 | $0 (2017) |
| Acorda Therapeutics, Inc | $22.97 | 1 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $22.50 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $309.05 | 21 | ABBVIE INC. ($281.25) |
| 2023 | $42.12 | 3 | Celgene Corporation ($28.67) |
| 2022 | $518.66 | 33 | ABBVIE INC. ($280.64) |
| 2021 | $320.24 | 30 | AbbVie Inc. ($176.38) |
| 2020 | $39.04 | 2 | Sunovion Pharmaceuticals Inc. ($27.04) |
| 2019 | $155.26 | 4 | Amgen Inc. ($91.32) |
| 2018 | $168.16 | 6 | Amgen Inc. ($108.84) |
| 2017 | $373.34 | 12 | Teva Pharmaceuticals USA, Inc. ($212.90) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $78.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $27.80 | General |
| 09/17/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/19/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Neuroscience | ||||||
| 08/10/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: Neuroscience | ||||||
| 12/15/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 254 | 16,454 | $197,965 | $110,946 |
| 2022 | 9 | 245 | 16,009 | $187,727 | $102,939 |
| 2021 | 8 | 239 | 15,896 | $188,904 | $103,679 |
| 2020 | 7 | 170 | 13,915 | $155,780 | $81,317 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 16,150 | $124,249 | $80,038 | 64.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 83 | $20,750 | $10,196 | 49.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 16 | 55 | $16,500 | $5,576 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 68 | $11,900 | $5,566 | 46.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $6,600 | $3,190 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,826 | $2,691 | 39.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 16 | 16 | $4,920 | $2,038 | 41.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 23 | 24 | $4,920 | $1,077 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,300 | $572.38 | 44.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 28 | 15,735 | $121,197 | $74,982 | 61.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 62 | $15,500 | $7,556 | 48.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 19 | 58 | $17,400 | $6,087 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 56 | $9,800 | $4,565 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $9,010 | $3,805 | 42.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $3,900 | $2,068 | 53.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 14 | 14 | $4,200 | $1,962 | 46.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 25 | 27 | $5,400 | $1,354 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,320 | $561.07 | 42.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 27 | 15,625 | $120,345 | $73,037 | 60.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 64 | $16,000 | $8,449 | 52.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 20 | 61 | $18,300 | $6,727 | 36.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $9,009 | $4,078 | 45.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 46 | $8,050 | $3,863 | 48.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $6,300 | $3,655 | 58.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 17 | 17 | $5,100 | $2,351 | 46.1% |
About Dr. Ryan Evans, M.D
Dr. Ryan Evans, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245242981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Evans, M.D has received a total of $1,926 in payments from pharmaceutical and medical device companies, with $309.05 received in 2024. These payments were reported across 111 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,632).
As a Medicare-enrolled provider, Evans has provided services to 908 Medicare beneficiaries, totaling 62,274 services with total Medicare billing of $398,880. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Rochester, NY
- Active Since 08/12/2006
- Last Updated 08/15/2012
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1245242981
Products in Payments
- UBRELVY (Drug) $348.37
- ZEPOSIA (Drug) $305.06
- BOTOX (Biological) $186.37
- QULIPTA (Drug) $183.65
- Aimovig (Biological) $183.62
- COPAXONE (Drug) $141.84
- BOTOX NEURO REHAB (Drug) $89.76
- LINZESS (Drug) $75.99
- KYNMOBI (Drug) $27.04
- DUOPA (Drug) $24.33
- RS Harmony Test Related Products (Device) $24.00
- INBRIJA (Drug) $22.97
- TROKENDI XR (Drug) $22.50
- Trudhesa (Drug) $21.95
- VYALEV (Drug) $21.31
- Mavenclad (Biological) $18.47
- EMGALITY (Drug) $16.13
- NAMZARIC (Drug) $13.88
- Dhivy (Drug) $13.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Rochester
Dr. Yucai Wang, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $1.1M
Kevin Perry, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $675,526
Arjun Sebastian, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $132,513
Benjamin Tracy
Student in an Organized Health Care Education/Training Program — Payments: $112,594
Dr. Vijay Agarwal, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $105,512
Mr. Timothy Brown, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $89,868